2022 연구성과별 연구자 정보 (43 / 2879)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| A Multicenter Study to Identify the Respiratory Pathogens Associated with Exacerbation of Chronic Obstructive Pulmonary Disease in Korea | Park, Yeonhee | Park, Y | 24 | Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Div Pulm & Crit Care Med,Dept Internal Med, Seoul, South Korea | 0000-0001-9537-1530 | Park, Yeonhee | khyou@kuh.ac.kr;kimdkmd@snu.ac.kr; | |||
| A Multicenter Study to Identify the Respiratory Pathogens Associated with Exacerbation of Chronic Obstructive Pulmonary Disease in Korea | Yoon, Young-Soon | Yoon, YS | 25 | Dongguk Univ, Ilsan Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Goyang, South Korea | khyou@kuh.ac.kr;kimdkmd@snu.ac.kr; | |||||
| A Multicenter Study to Identify the Respiratory Pathogens Associated with Exacerbation of Chronic Obstructive Pulmonary Disease in Korea | Park, Joo Hun | Park, JH | 26 | Ajou Univ, Sch Med, Dept Pulm & Crit Care Med, Suwon, South Korea | AAP-9425-2020 | Park, Joo | khyou@kuh.ac.kr;kimdkmd@snu.ac.kr; | |||
| A Multicenter Study to Identify the Respiratory Pathogens Associated with Exacerbation of Chronic Obstructive Pulmonary Disease in Korea | Yoo, Kwang Ha | Yoo, KH | 27 | 교신저자 | Konkuk Univ, Sch Med, Dept Internal Med, Seoul, South Korea | khyou@kuh.ac.kr;kimdkmd@snu.ac.kr; | ||||
| A Multicenter Study to Identify the Respiratory Pathogens Associated with Exacerbation of Chronic Obstructive Pulmonary Disease in Korea | Kim, Deog Kyeom | Kim, DK | 28 | 교신저자 | Seoul Natl Univ, Seoul Metropolitan Govt, Dept Internal Med, Coll Med,Div Pulm & Crit Care Med,Boramae Med Ctr, Seoul, South Korea | khyou@kuh.ac.kr;kimdkmd@snu.ac.kr; | ||||
| A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naive, high-risk essential thrombocythemia as a primary treatment | Byun, Ja Min | Byun, JM | 1 | Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea | AAI-2125-2020 | Byun, Ja | shindongyeop@snu.ac.kr;ssysmc@snu.ac.kr; | |||
| A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naive, high-risk essential thrombocythemia as a primary treatment | Kim, Ho Young | Kim, HY | 2 | Hallym Univ, Dept Internal Med, Med Ctr, Anyang, South Korea | HTR-7982-2023 | Kim, Ho-Young | shindongyeop@snu.ac.kr;ssysmc@snu.ac.kr; | |||
| A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naive, high-risk essential thrombocythemia as a primary treatment | Nam, Seung-Hyun | Nam, SH | 3 | Kyung Hee Univ Gangdong, Dept Internal Med, Seoul, South Korea | GYJ-4373-2022 | Nam, Seung-Hyun | shindongyeop@snu.ac.kr;ssysmc@snu.ac.kr; | |||
| A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naive, high-risk essential thrombocythemia as a primary treatment | Shin, Ho-Jin | Shin, HJ | 4 | Pusan Natl Univ Hosp, Med Res Inst, Sch Med, Dept Internal Med,Div Haematol Oncol, Pusan, South Korea | shindongyeop@snu.ac.kr;ssysmc@snu.ac.kr; | |||||
| A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naive, high-risk essential thrombocythemia as a primary treatment | Song, Seulki | Song, SL | 5 | Seoul Natl Univ Hosp, Canc Res Inst, Seoul, South Korea | shindongyeop@snu.ac.kr;ssysmc@snu.ac.kr; | |||||
| A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naive, high-risk essential thrombocythemia as a primary treatment | Park, Jinny | Park, J | 6 | Gachon Univ, Dept Internal Med, Div Hematol, Gil Med Ctr, Incheon, South Korea | KIB-5533-2024 | Park, Junsik | 0009-0005-3186-3591 | Park, Jinny | shindongyeop@snu.ac.kr;ssysmc@snu.ac.kr; | |
| A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naive, high-risk essential thrombocythemia as a primary treatment | Han, Sang Hoon | Han, SH | 7 | Jeju Natl Univ, Jeju Natl Univ Hosp, Dept Internal Med, Sch Med, Jeju, South Korea | 0000-0003-0976-9134 | Han, Sanghoon | shindongyeop@snu.ac.kr;ssysmc@snu.ac.kr; | |||
| A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naive, high-risk essential thrombocythemia as a primary treatment | Park, Yong | Park, Y | 8 | Korea Univ, Dept internal Med, Div Hematooncol, Sch Med, Seoul, South Korea | shindongyeop@snu.ac.kr;ssysmc@snu.ac.kr; | |||||
| A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naive, high-risk essential thrombocythemia as a primary treatment | Yuh, Young Jin | Yuh, YJ | 9 | Inje Univ, Sanggye Paik Hosp, Dept Internal Med, Coll Med, Seoul, South Korea | shindongyeop@snu.ac.kr;ssysmc@snu.ac.kr; | |||||
| A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naive, high-risk essential thrombocythemia as a primary treatment | Mun, Yeung-Chul | Mun, YC | 10 | Ewha Womans Univ, Coll Med, Dept Internal Med, Mokdong Hosp, Seoul, South Korea | shindongyeop@snu.ac.kr;ssysmc@snu.ac.kr; |
페이지 이동: